Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

BUSINESS COMBINATIONS - Disclosure of fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details)

v3.22.2.2
BUSINESS COMBINATIONS - Disclosure of fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details)
₪ in Thousands, $ in Thousands
Jun. 30, 2022
CAD ($)
Dec. 31, 2021
CAD ($)
Apr. 30, 2021
CAD ($)
Apr. 30, 2021
ILS (₪)
Disclosure of detailed information about business combination [line items]        
Advance payment for intangible assets of pharmacy $ 6,173 $ 3,129    
Panaxia [Member]        
Disclosure of detailed information about business combination [line items]        
Total purchase price     $ 7,000 ₪ 18,700
Panaxia [Member] | Preliminary PPA [Member]        
Disclosure of detailed information about business combination [line items]        
Inventory 19      
Advance payment for intangible assets of pharmacy 2,837      
Property, plant and equipment 88      
Intangible assets 776      
Total identifiable assets 3,720      
Goodwill arising on acquisition 3,240      
Total purchase price 6,960      
Panaxia [Member] | Adjustments [Member]        
Disclosure of detailed information about business combination [line items]        
Inventory 0      
Advance payment for intangible assets of pharmacy 3,367      
Property, plant and equipment 0      
Intangible assets (593)      
Total identifiable assets 2,774      
Goodwill arising on acquisition (2,774)      
Total purchase price 0      
Panaxia [Member] | Final PPA [Member]        
Disclosure of detailed information about business combination [line items]        
Inventory 19      
Advance payment for intangible assets of pharmacy 6,204      
Property, plant and equipment 88      
Intangible assets 183      
Total identifiable assets 6,494      
Goodwill arising on acquisition 466      
Total purchase price $ 6,960